Page last updated: 2024-09-04

arginylproline and Urinary Bladder Neoplasms

arginylproline has been researched along with Urinary Bladder Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Fernández-Pérez, C; Garde-García, H; Maestro-de Las Casas, M; Moreno-Sierra, J; Redondo-González, E	1

Other Studies

1 other study(ies) available for arginylproline and Urinary Bladder Neoplasms

Article	Year
Biomarkers and intermediate-high risk non-muscle invasive bladder cancer: a multivariate analysis of three different cellular pathways with pronostic implications. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2021, Volume: 23, Issue:4 Topics: Aged; Analysis of Variance; Biomarkers, Tumor; Codon; Dipeptides; Disease Progression; Female; Genes, p53; Genes, ras; Genetic Markers; Humans; Male; Microsatellite Instability; Microsatellite Repeats; Neoplasm Recurrence, Local; Point Mutation; Prognosis; Prospective Studies; Sex Factors; Time Factors; Urinary Bladder Neoplasms	2021

Article

Year

Biomarkers and intermediate-high risk non-muscle invasive bladder cancer: a multivariate analysis of three different cellular pathways with pronostic implications.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2021, Volume: 23, Issue:4

Topics: Aged; Analysis of Variance; Biomarkers, Tumor; Codon; Dipeptides; Disease Progression; Female; Genes, p53; Genes, ras; Genetic Markers; Humans; Male; Microsatellite Instability; Microsatellite Repeats; Neoplasm Recurrence, Local; Point Mutation; Prognosis; Prospective Studies; Sex Factors; Time Factors; Urinary Bladder Neoplasms

2021